Pictet Asset Management (UK)’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-12,000
| Closed | -$187K | – | 1818 |
|
|
2020
Q4 | $187K | Hold |
12,000
| – | – | ﹤0.01% | 1616 |
|
|
2020
Q3 | $113K | Buy |
+12,000
| New | +$113K | ﹤0.01% | 1486 |
|
|
2020
Q1 | – | Sell |
-1,350,377
| Closed | -$11.3M | – | 1147 |
|
|
2019
Q4 | $11.3M | Buy |
1,350,377
+715,436
| +113% | +$5.99M | 0.02% | 537 |
|
|
2019
Q3 | $5.75M | Hold |
634,941
| – | – | 0.01% | 658 |
|
|
2019
Q2 | $6.84M | Buy |
634,941
+200,000
| +46% | +$2.15M | 0.01% | 605 |
|
|
2019
Q1 | $4.15M | Buy |
434,941
+3,947
| +0.9% | +$37.7K | 0.01% | 723 |
|
|
2018
Q4 | $4.95K | Buy |
430,994
+80,486
| +23% | +$924 | 0.01% | 662 |
|
|
2018
Q3 | $5.94M | Buy |
350,508
+50,903
| +17% | +$863K | 0.01% | 673 |
|
|
2018
Q2 | $4.25M | Buy |
+299,605
| New | +$4.25M | 0.01% | 697 |
|